We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Orthopedic Company Comes Under SEC Scrutiny

Law360 (November 21, 2006, 12:00 AM EST) -- Orthopedic products company ReGen Biologics Inc. said Monday that it has received a letter from the U.S. Securities and Exchange Commission’s Division of Enforcement requesting information regarding the company’s stock options-granting...
To view the full article, register now.